-
Vision in Sight — Vuzix Outlines Ultra-Sleek Lineup of Smart Glasses, CES 2022 Presence, and Partnerships
Previously Published to Benzinga It’s a new year, and 2022 may just become the Year of the Meta with virtual reality (VR), augmented reality (AR), and extended reality (XR) around every corner. Vuzix Corp. (NASDAQ: VUZI) is arguably no exception, leaving 2021 with a bang and entering the new year fresh-faced and making moves. The company is a leading supplier of smart glasses and AR technologies, developing innovative products primarily focused on enterprise markets. This includes personal displays and wearable computing devices triggered by touchpad, voice, and Bluetooth inputs. In addition, it offers users a portable, high-quality viewing experience, shared view video streaming, and dynamic solutions for mobility purposes. That means…
-
Evariant Awarded Funding to Innovate Healthcare CRM
Previously Published to TMC Net’s HealthTech Zone Evariant, which offers an end-to-end CRM solution, has announced it received $42.3M in Series C financing through financial institution, Goldman Sachs, which will be used toward innovations in their current CRM healthcare platform for providers. The company also said it secured both Series A and B leads in Health Enterprise Partners and Lightspeed Venture Partners, who have raised additional funding on behalf of the brand. With over $70M in funding, the startup plans to focus on growth and evolution of their platform, starting with service lines, engineering and customer success teams. Recently opening a fourth office in Austin, this capital will allow Evariant…
